Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia
about
High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.Predictive performance of a gentamicin population pharmacokinetic model in neonates receiving full-body hypothermiaAltered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia.Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermiaRenal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?Dosing antibiotics in neonates: review of the pharmacokinetic data.Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.A Population Pharmacokinetic Analysis to Study the Effect of Therapeutic Hypothermia on Vancomycin Disposition in Children Resuscitated From Cardiac Arrest.Effect of Hypothermia and Targeted Temperature Management on Drug Disposition and Response Following Cardiac Arrest: A Comprehensive Review of Preclinical and Clinical Investigations.Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy.Decreased Morphine Clearance in Neonates With Hypoxic Ischemic Encephalopathy Receiving Hypothermia.Pharmacokinetics of gentamicin in newborns with moderate-to-severe hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia.Population pharmacokinetics of levetiracetam in neonates with seizures.Quantitative analysis of gentamicin exposure in neonates and infants calls into question its current dosing recommendations.
P2860
Q33812116-F1ACC2D2-3EF4-4112-BC25-E71CF83639D1Q34200271-B5E8B831-9C96-4B2C-A702-C2677A245EC6Q36924742-D3718EC0-E482-4093-9057-16301FD44772Q37146686-1B698491-1A30-45F2-B7BB-2C33E825C740Q38594191-1D6A797F-9B6E-475A-89FA-AD060C901B7CQ38649419-50B18D76-91E1-4800-8ED7-5C2C10F7452EQ38696468-9D133764-CABC-49EB-B108-21F24E04A703Q38798212-5D47B319-1353-4E67-932F-6040DB5C9A99Q38953221-9F884FB8-3C3F-47DC-994B-DF6CCE4B1820Q39071799-B10EA287-2835-4C3F-B18F-9DADE3FF3D1DQ39735912-DDE86849-02DF-4B0D-87FC-4E0076F08BCBQ45822404-592E3A31-FF03-4FE3-B16A-5032F3671694Q48371247-F5DCE941-7B03-4EF8-9C49-3F29E57D03F0Q48514081-2E39DA51-4071-4F9E-9859-22FF7F06B4D4
P2860
Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Gentamicin pharmacokinetics an ...... alopathy receiving hypothermia
@en
type
label
Gentamicin pharmacokinetics an ...... alopathy receiving hypothermia
@en
prefLabel
Gentamicin pharmacokinetics an ...... alopathy receiving hypothermia
@en
P2093
P2860
P356
P1433
P1476
Gentamicin pharmacokinetics an ...... alopathy receiving hypothermia
@en
P2093
Adam Frymoyer
B Joseph Guglielmo
Davide Verotta
Sonia L Bonifacio
P2860
P304
P356
10.1002/PHAR.1263
P407
P577
2013-04-01T00:00:00Z